Evaluation of Cerebrovascular Hemodynamics With Transcranial Doppler and Near-infrared Spectroscopy in Patients With Multiple Sclerosis

CompletedNot a drug-phase studyRelapsing and progressiveNCT02389426

What it found

No results found

We found no results in the registry or in papers.

This trial finished 11 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • TCD baseline
  • TCD after bosentan administration
  • NIRS baseline
  • NIRS after bosentan administration

What it measured

Main measures

  • Detection of hemodynamic differences between MS patients and Healthy controls with TCD baseline.

    a 10 minute recording with TCD baseline

Other measures (3)

  • Hemodynamic changes in MS patients detected with TCD after administration of Bosentan

    baseline and 4 hours after administration of bosentan a 10 minute recording with TCD

  • Detection of frontal lobe oxygen saturation differences between patients with multiple sclerosis and healthy controls with near-infrared spectroscopy.

    a 10 minute recording with NIRS baseline

  • Frontal lobe oxygen saturation changes in MS patients detected with NIRS after administration of Bosentan

    baseline and 4 hours after administration of bosentan a 10 minute recording with NIRS

Who could take part

Relapsing and progressive · 18 and over

Show the full criteria

Inclusion criteria

* Patients with the diagnosis of relapsing-remitting, primary progressive of secondary progressive MS, according to the 2010 revised McDonald criteria. * Written informed consent must be obtained.

Exclusion criteria

* MS patients with a known contra-indication for bosentan: liver dysfunction, use of cyclosporine A, allergy. * Pregnancy * No evidence of MS relapse within the 3 months prior to inclusion.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The aim of this study is to investigate the potential of Transcranial doppler (TCD) and Near-Infrared Spectroscopy (NIRS), more simple and non-invasive bedside methods than magnetic resonance imaging (MRI), to evaluate changes in the cerebral circulation between patients with MS and control subjects.

Papers

Loading reviews and guidelines…

History

    1. Started

      Dec 2014

    2. Main results due

      Mar 2015

    3. Finished

      Apr 2015

    Assembled by software from public sources.